Send the following on WhatsApp
Continue to ChatGlenmark becomes the first company to launch Remogliflozin + Vildagliptin + Metformin fixed dose combination, at an affordable price for adults with Type 2 Diabetes in India https://asianmail.in/2021/10/26/glenmark-becomes-the-first-company-to-launch-remogliflozin-vildagliptin-metformin-fixed-dose-combination-at-an-affordable-price-for-adults-with-type-2-diabetes-in-india/